Evidence map›Paper›PMID 32286303›Full record

ArticleNature communications2020

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.

Jay Daniels, Peter G Doukas, Maria E Martinez Escala, Kimberly G Ringbloom, David J H Shih, Jingyi Yang, Kyle Tegtmeyer, Joonhee Park, Jane J Thomas, Mehmet E Selli and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Through thick and thin: confronting the aggressive cutaneous T-cell lymphomas.Hematology. American Society of Hematology. Education Program · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Recent advances in cutaneous lymphoma-implications for current and future classifications.Virchows Archiv : an international journal of pathology · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 1 country.

Jay Daniels *Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-4022-6795
Peter G Doukas *Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-6242-5395
Maria E Martinez EscalaDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kimberly G RingbloomDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
David J H ShihDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9802-4937
Jingyi YangDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kyle TegtmeyerDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-5828-6991
Joonhee ParkDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-6209-6923
Jane J ThomasDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Mehmet E SelliDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Can AltunbulakliDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ragul GowthamanUniversity of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.ORCID http://orcid.org/0000-0002-0008-6401
Samuel H MoUniversity of Illinois College of Medicine, Chicago, IL, USA.
Balaji JothishankarDepartment of Medicine, Section of Dermatology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-2037-0175
David R PeaseDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-0472-1900
Barbara ProDivision of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Farah R AbdullaDivision of Dermatology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Christopher SheaDepartment of Medicine, Section of Dermatology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Nidhi SahniDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9155-5882
Alejandro A GruDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA.ORCID http://orcid.org/0000-0002-2573-8074
Brian G PierceUniversity of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.ORCID http://orcid.org/0000-0003-4821-0368
Abner LouissaintDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA. alouissaint@partners.org.
Joan GuitartDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. JGUITART@nm.org.
Jaehyuk ChoiDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. jaehyuk.choi@northwestern.edu.ORCID http://orcid.org/0000-0003-2379-2226
Northwestern University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Chicago · USUniversity of Maryland, Baltimore · USCity of Hope · USIllinois College · USMassachusetts General Hospital · USUniversity of Virginia Health System · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
CARCINOGENESIS TRAINING PROGRAMT32CA009560 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Kathleen Janee Green · 1986 to 2026
$8.4M
Northwestern University Skin Disease Research Center Resource-based CenterP30AR075049 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Irina Budunova · 2019 to 2026
$6.6M
The Role of Keratinocytes as Independent ThermosensorsP30AR057216 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PALLER, AMY S · 2009 to 2018
$6.0M
Short Term Training: Health Professional StudentsT35DK062719 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 2003 to 2017
$2.9M
Identifying Mechanisms Governing T Cell DiversityDP2AI136599 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHOI, JAEHYUK · 2017 to 2017
$2.4M
High Resolution Modeling and Design of T-Cell ReceptorsR01GM126299 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI PIERCE, BRIAN G. · 2018 to 2021
$1.3M
The Role of ZEB1 Mutations in Cutaneous T Cell LymphomaK08CA191019 · NCI · YALE UNIVERSITY · PI CHOI, JAEHYUK · 2015 to 2019
$760k
NCI NIH HHS K08 CA191019NCI NIH HHS T32 CA009560NIAID NIH HHS DP2 AI136599NIAMS NIH HHS P30 AR057216NIAMS NIH HHS P30 AR075049NIDDK NIH HHS T35 DK062719NIGMS NIH HHS R01 GM126299NIGMS NIH HHS T32 GM008152
6 · The paper itself

Abstract

Primary cutaneous γδ T cell lymphomas (PCGDTLs) represent a heterogeneous group of uncommon but aggressive cancers. Herein, we perform genome-wide DNA, RNA, and T cell receptor (TCR) sequencing on 29 cutaneous γδ lymphomas. We find that PCGDTLs are not uniformly derived from Vδ2 cells. Instead, the cell-of-origin depends on the tissue compartment from which the lymphomas are derived. Lymphomas arising from the outer layer of skin are derived from Vδ1 cells, the predominant γδ cell in the epidermis and dermis. In contrast, panniculitic lymphomas arise from Vδ2 cells, the predominant γδ T cell in the fat. We also show that TCR chain usage is non-random, suggesting common antigens for Vδ1 and Vδ2 lymphomas respectively. In addition, Vδ1 and Vδ2 PCGDTLs harbor similar genomic landscapes with potentially targetable oncogenic mutations in the JAK/STAT, MAPK, MYC, and chromatin modification pathways. Collectively, these findings suggest a paradigm for classifying, staging, and treating these diseases.

Indexed as

Amino Acid SequenceAntigens, CD1dChromatin Assembly and DisassemblyEpitopesGenome, HumanHEK293 CellsHumansLymph NodesLymphoma, T-Cell, CutaneousModels, BiologicalMutationPhenotypePrincipal Component AnalysisReceptors, Antigen, T-Cell, gamma-deltaSignal TransductionSkinAntigens, CD1dEpitopesReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID32286303
PMCPMC7156460
OpenAlexW3016153237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.